| Identification | Back Directory | [Name]
Imidazo[1,5-a]pyrazine-2(3H)-propanoic acid, 7-[[(6S)-5-(ethoxycarbonyl)-6-(3-fluoro-2-methylphenyl)-3,6-dihydro-2-(2-thiazolyl)-4-pyrimidinyl]methyl]hexahydro-α,α-dimethyl-3-oxo-, (8aS)- | [CAS]
1808248-05-6 | [Synonyms]
RG-7907
Linvencorvir
Imidazo[1,5-a]pyrazine-2(3H)-propanoic acid, 7-[[(6S)-5-(ethoxycarbonyl)-6-(3-fluoro-2-methylphenyl)-3,6-dihydro-2-(2-thiazolyl)-4-pyrimidinyl]methyl]hexahydro-α,α-dimethyl-3-oxo-, (8aS)- | [Molecular Formula]
C29H35FN6O5S | [MOL File]
1808248-05-6.mol | [Molecular Weight]
598.69 |
| Chemical Properties | Back Directory | [Boiling point ]
748.2±70.0 °C(Predicted) | [density ]
1.43±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
4.72±0.10(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
Linvencorvir is an antiviral agent[1]. | [References]
[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021 |
|
|